Obstructive Sleep Apnea: Beyond Obesity by Garg, Rajiv et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 4
Obstructive Sleep Apnea: Beyond Obesity
Rajiv Garg, Anand Srivastava and
Jagadeesha N. Halekote
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/67587
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, 
and reproduction in any medium, provided the original work is properly cited. 
Rajiv Garg, Anand Srivastava and 
Jagadeesha N. Halekote
Additional information is available at the end of the chapter
Abstract
Sleep disorders are of growing concern and are a major public health problem. The obstruc-
tive sleep apnea (OSA) is the most common among different sleep-related breathing dis-
orders (SRBDs). Obesity is a known associated risk factor for the OSA but is not limited 
to them. OSA is also recognized in nonobese population. The description of OSA in non 
obese patients in the literature is sparse. The clinical presentation is similar as in obese 
but has few differences as far as pathophysiology and polysomnographic features are con-
cerned. The severity of OSA in nonobese has less severe manifestations thus requires early 
recognition and  different treatment strategy to prevent mismanagement of these patients.
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1. Introduction
Sleep disorders are of growing concern and has become a major public health  problem. 
Sleep disorders involve difficulty in breathing during sleep and are grouped under 
 sleep-related breathing disorders (SRBDs). SRBDs are commonly classified as central sleep 
apnea  syndrome, obstructive sleep apnea syndrome, hypoventilation/hypoxia syndrome, 
 nonspecific/ undefined sleep disorder [1]. Among SRBDs, obstructive sleep apnea (OSA) 
is the most common. OSA has characteristically been associated with obesity and lack of 
awareness and ignorance has contributed more to its increasing prevalence. OSA escaped the 
thought of many doctors till it was first described by Gastaut in a Neurology journal in 1965. 
Although it was first observed and mentioned in a book of Charles Dickens, an English book 
writer, in 1936 about a character of a person by name Joe (fat boy) in his book, The Pickwick 
Papers [2]. According to Dacal Quintas et al. [3], frequency and severity of OSA in normal 
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weight patients was lower than overweight and obese patients. They reported frequency 
of 70.52 and 22% OSA in obese and normal weight patients, respectively. Normal weight 
group patients were mainly women, snorers, nonsmokers, nondrinkers and were signifi-
cantly younger and with a smaller neck and waist circumference. The exact and recent data 
regarding prevalence of OSA in nonobese are not available. However, the recent studies have 
shown a wide scope for the evaluation of the OSA among nonobese patients globally and in 
India. Physicians noticed that the clinical presentations of OSA are not only limited in obese 
but also found in nonobese [4]. The common clinical presentation in obese and nonobese is 
the outcome of the basic  underlying pathophysiological change that is airway narrowing or 
collapse during the sleep which may have different determinants that are being addressed 
in this chapter.
2. Pathophysiology of airway obstruction
OSA is a major public health problem affecting sizeable population. The  patho physiologi-
cal mechanism of OSA is not thoroughly understood and it appears to be of  multifactorial 
origin which majorly involves interaction between anatomical (static),  functional (dynamic), 
and systemic factors. Although these factors form the basis of OSA in nonobese and obese 
persons, their contribution may differ in the two groups of people.
3. Mechanism of airway obstruction during sleep
Pharynx is the only collapsible segment of the respiratory tract (except nares and small 
 airways), and it is also the site for upper airway closure or narrowing during sleep. The 
patency of the pharynx is maintained by two counteracting forces, i.e. upper airway  muscles 
(dilates and stiffens the pharynx) and negative intraluminal pressure (tends to narrow the 
pharynx). The imbalance between these two is the basis for OSA. Retropalatal and retro-
glossal areas of oropharynx are the commonly involved site in the narrowing of airways in 
OSA [5, 6].
The reasons for narrowing in OSA are different in nonobese and obese patients in comparison 
with normal individual [7]. In OSA, upper airway soft tissue enlargement may play a more 
important role in obese patients, whereas bony structure discrepancies may be the dominant 
contributing factors among nonobese patients. The various factors responsible for OSA in 
nonobese are mentioned below (Figure 1).
3.1. Anatomical (Static) factors in upper airway structure
(1) Edema: Negative pressure due to airway closure and repeated apnea may lead to edema 
of soft tissues particularly uvula and genioglossus [8–10].
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(2) Muscle injury: Repeated fatigue of upper airway muscles in sleep apnea leads to myopa-
thy which in turn results in remodeling of muscles [11, 12].
(3) Gender: Upper airway size and neck size are smaller in women than in men, thus the 
size of soft tissue structures is also smaller in women than in men. Fat deposition in men 
is  primarily seen in upper body and trunk, whereas in women fat is deposited more 
 commonly in lower body and extremities [13–15].
The above factors contribute to the development of OSA in both obese and nonobese. Obesity 
is a major risk factor for OSA, where there is decrease in pharyngeal airway size and increases 
airway collapsibility. Increase in neck size associated with an increase in BMI, seen in OSA 
patients, is a good predictor of sleep apnea. Weight gain is associated with generalized fat 
deposition, which contributes to the increase in the oropharyngeal  muscle mass  responsible 
for its malfunctioning and thus airway collapsibility [16–18].
3.2. Physiological (dynamic) factors in upper airway structure
The data indicate that the upper airway collapsibility during apneic events occurs at the end 
of expiration in addition to collapse during inspiration [19, 20]. During wakefulness, the 
Figure 1. Factors responsible for OSA in nonobese.
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 balance between the upper airway dilator muscles and negative intraluminal pressure leads 
to a constant upper airway caliber [21, 22]. During sleep (in normal subject), it is associated 
with narrowing of pharyngeal luminal area due to decrease in upper airway muscle activity 
and a persistence of subatmospheric luminal pressure during inspiration. When the severity 
of this narrowing increases along with the anatomical impairment, this may lead to the devel-
opment of OSA during sleep.
3.3. Systemic factors affecting upper airway structure
Accumulated fluid in the leg has a tendency to suffer overnight rostral displacement to the 
parapharyngeal region. Additionally, this rostral fluid displacement further interacts with 
the displacement of subcutaneous tissue, thus compromising the pharyngeal airway lumen. 
Few published articles, all in nonobese subjects, confirmed overnight increase in neck 
 circumference resulting from shift of fluid from the legs [23–25]. This has further been proved 
by  experimental studies using medical antishock trousers (MAST) [26, 27]. Organ failures 
such as heart failure [28], renal failure [29], and other disease conditions such as  hypertension 
[30–32], stroke [33, 34], pulmonary arterial hypertension [35], and other conditions with 
potential for fluid retention are associated with OSA.
3.4. Other factors
Upper airway resistance syndrome (UARS) can be considered as the other factor, though 
the debate has been in existence since Guilleminault et al. first described UARS in 1993 [36]. 
The UARS has clinical presentations similar to OSA but certain differences are found in OSA 
and UARS. Many authors have tried to differentiate these two entities but only could reach 
to a very thin line of demarcation [37, 38]. The fact remains that UARS is commonly seen in 
 nonobese, with body mass index (BMI) ≤25 kg/m2 [39, 40]. Patients are frequently younger 
than patients with OSAS. UARS is more common in males but the female to male ratio seems 
to be highest in UARS group compared to OSA [41]. Frequent arousals due to increased 
respiratory effort also known as respiratory effort-related arousals (RERAs) in UARS are 
associated with daytime sleepiness, functional symptoms, cardiovascular, and cognitive 
disturbances. These RERAs are the classical features of UARS [42]. Unfortunately, many 
UARS patients are still under diagnosed as these patients are not subjected to polysomno-
graphic studies as belief that patients must be obese or at least overweight with a large neck 
and these patients are usually labeled as fibromyalgia, chronic fatigue syndrome, or as psy-
chiatric disorders, such as attention deficit disorder/attention deficit hyperactivity disorder 
(ADD/ADHD) [43].
The pathophysiology of UARS appears to be similar to OSA despite subtle differences in 
them. In UARS, pharyngeal reflexes are preserved compared to impaired reflexes in OSA 
[44]. Nocturnal polysomnography in UARS does not show apneas or hypopneas, which are 
the main features of obstructive sleep apnea syndrome (OSAS). Even though UARS does not 
have apneas/hypopneas, RERAs are associated with significant disturbances in sleep leading 
to impairment of daily routine of individuals. So ICSD II recommends that UARS should be 
considered as a part of OSA and not as a separate entity [45].
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4. Causes for OSA in nonobese patients
Along with UARS and organ failure, causes for OSA in nonobese patients are mainly limited 
to several cephalometric defects compared with their BMI matched normal controls [7].
Nonobese OSA patients tend to present the following anatomical craniofacial characteristics, 
such as caudal hyoid, increased soft palate dimensions, and consequent anterior-posterior 
reductions of the airways at the soft palate level, reduction of anterior-posterior region of 
nasopharynx and oropharynx [7].
It has been suggested that the discrepancy in these cephalometric measurements may also 
depend on sex, age, and race [46–49]. OSA in Asian men has been found more frequently in 
the nonobese patients, despite the presence of severe illness, when compared with white male 
patients with OSAS [50].
Garg et al. [4] reported that nonobese subjects were more likely in habit of taking sedatives for 
sleeping when compared to obese counterpart, which was in concordance with other study 
conducted by Ghanem and Mahmood on 102 patients with OSA [51].
5. Clinical manifestations
There is no much difference between the clinical features of OSA in obese and nonobese as the 
pathophysiology of OSA is same in both obese and nonobese patients. Point of differentiation 
comes at severity of symptoms and management. Frequency and severity of OSA in nonobese 
is comparatively less than OSA in obese [3].
According to the study conducted by the author, the obese group had a significance with 
regard to lower minimal oxygen saturation (68.47 ± 13.00 vs. 80.25 ± 7.40, P < 0.001), higher 
average desaturation index (48.32 ± 13.08 vs. 30.63 ± 15.63, P < 0.001), and higher arousal index 
(28.42 ± 4.99 mm vs. 17.84 ± 5.07 mm, P < 0.001). Although there were a large number of obese 
patients than nonobese in the study (25/45 vs. 14/36) having minimum oxygen saturation 
<90%, the percentage of nonobese patients showing similar findings was not less (55.6 vs. 38.9, 
P = 0.37). The rest of the polysomnographic parameters were comparable [4].
6. Diagnosis
Diagnosis of OSA should be made after a comprehensive work up on the basis of history, 
examination, polysomnography, limited channel testing, split-night testing, and oximetry.
Since in most of these patients anatomical factors contribute to their problem, thus the empha-
sis should be to assess the airway thoroughly.
Airway may be assessed with the help of a number of imaging modalities such as  acoustic 
reflexion, fluoroscopy, nasopharyngoscopy, and cephalometry (Figures 2 and 3; Table 1), 
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Figure 2. Cephalometric landmarks A.
Figure 3. Cephalometric landmarks B.
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S Center of sella turcica
N Nasion, the deepest point concavity of nasofrontal suture
ANS Anterior nasal spine
PNS Posterior nasal spine
Point A The deepest point in the concavity of the anterior maxilla between the anterior nasal spine and 
the alveolar crest
Point B The deepest point in the concavity of the anterior mandible between the alveolar crest and pogonion
Go Gonion, the most posteroinferior point on angle of mandible
Me The most inferior point on bony chin
U The tip of uvula
OV Intersection point between line on maximal diameter of velum in oronasal direction and oral 
surface of velum
NV Intersection point between line of maximal diameter of velum in oronasal direction and nasal 
surface of velum
T Intersection point between dorsal surface of tongue and line perpendicular to maxillary plane at 
PNS
H The most superior and anterior point on the body of hyoid bone
a
C
3
Anteroinferior point on corpus of third cervical vertebrae (C3)
p
C
3
Posteroinferior point on corpus of third cervical vertebrae (C3)
a
C
4
Anteroinferior point on corpus of fourth cervical vertebrae (C4)
a
P
u
Intersection point between anterior pharyngeal wall and line passing through point ‘U’ parallel to 
maxillary plane
p
P
u
Intersection point between posterior pharyngeal wall and line passing through point ‘U’ parallel 
to maxillary plane
p
P
o
Intersection point between nasal line and posterior pharyngeal wall
p
P
3
Intersection point between line connecting points, 
P
C
3
 and 
a
C
3
 and posterior pharyngeal wall
ANS-PNS Maxillary plane
Go-Me Mandibular plane (MP); line tangent to lower border of body of mandible through gnathion
H-MP Distance between H and mandibular plane
S-H Distance between S and H
a
C
4
-H Distance between H and 
a
C
4
PNS-U Soft palate length
NV-OV Soft palate thickness
ANS-PNS-U Soft palate (SP) angle, angle between maxillary plane and soft palate
R
Radius of curvature of nasal surface of soft palate  r =   ( NV to OV distance )   ________________
2
 +  
 ( PNS to U distance ) 
2
 
  _________________
8 ( NV to OV distance ) 
 
a
P
u
 – 
p
P
u
Anteroposterior dimension of oropharynx at U
PNS-
p
P
0
-
p
P
3
-
a
P
3
-L Total pharyngeal area
Table 1.  Cephalometric landmarks and reference lines used.
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MR imaging, and both conventional and electron-beam CT scanning. MR imaging is  probably 
the best imaging modality, although still not ideal [52].
7. Treatment
Possible treatment options for adult patients with OSA should be based on the severity of 
the sleep disorder, preference of the patient, the patient’s general health, and the preference 
and experience of the team members. Treatment approach for OSA should be holistic and 
 multimodality. Positive airway pressure (PAP) is universally accepted as the treatment of 
choice for mild, moderate, and severe OSA and thus should be offered to all patients as the first 
option. Side effects and adverse events are mainly minor and reversible with CPAP and BPAP 
therapy [53]. It may be delivered in continuous (CPAP), bilevel (BPAP), or  autotitrating (APAP) 
modes. CPAP is indicated for the treatment of moderate-to-severe OSA [53]. Treatment of mild 
OSA could be optional other than PAP therapy. The American Academy of Sleep Medicine 
(AAOSM) has recommended the use of oral appliances (OAs) in patients with primary  snoring 
and mild-to-moderate OSA [52]. Oral appliances are not as efficacious as CPAP. They are 
 indicated for use in patients with mild-to-moderate OSA who prefer OAs to CPAP, or who 
do not respond to CPAP, are not appropriate candidates for CPAP, or who fail CPAP and are 
not fit candidate for surgery [54]. Oral appliances can also achieve satisfactory outcomes in 
UARS [55]. If surgical measures are predicted (severe obstructing anatomy that is surgically 
 correctible) to be highly effective in treating sleep apnea, upper airway surgery (including ton-
sillectomy and adenoidectomy, craniofacial operations, and tracheostomy) may also  supersede 
use of OAs. Surgical procedures may also be considered as a secondary treatment for OSA 
when the patient is intolerant of PAP, or PAP therapy is unable to eliminate OSA [56]. There 
are no widely effective pharmacotherapies for OSA. Topical nasal corticosteroids may improve 
the AHI in patients with OSA and concurrent rhinitis, and thus may be a useful adjunct to 
primary therapies for OSA. However, short-acting nasal decongestants are not recommended 
for treatment of OSA [56]. Oxygen supplementation has no role as a primary treatment for 
OSA [57]. Modafinil is recommended for the treatment as an add-on therapy of residual exces-
sive daytime sleepiness in OSA patients who have sleepiness despite effective PAP treatment 
and who are lacking any other identifiable and correctable cause for their sleepiness [57]. We 
 suggest that CPAP and Bi level is not the only modality of treatment. Any patient with systemic 
disorder requires treatment of primary disorder before application of these devices.
8. Conclusion
The severity of OSA in nonobese has less severe manifestation and requires different 
 treatment strategy according to the contributory factor playing in its causation. Patients also 
require thorough clinical evaluation and confirmation by means of polysomnographic  studies 
as many patients showing features of daytime sleepiness and fatigue may be erroneously 
managed as psychological symptoms.
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The OSA in nonobese can be missed in elderly patients who have comorbidities like cardio-
vascular and neurological disease along with weak oropharyngeal muscles leading to easy 
collapsibility of airway along with obstruction. Correction of OSA in nonobese person is a 
multimodality approach. Assessment of upper airway anatomical variation from normalcy 
is a crucial step of management. Besides maintenance of sleep hygiene, patient could be 
 subjected to many different modality of  treatment as a holistic approach.
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